阿迪波金可以预测临床预后和COVID后的肺部后果吗?
Dorina Esendagli1, Deniz Topcu2, Eylem Gul3
1Department of Chest Diseases, Baskent University, Faculty of Medicine, Ankara, Turkey.
低化学素水平表明COVID-19患者的预后更差. 化学素/阿迪波涅克丁比率可以预测COVID后肺部后续病变的发展,有助于患者管理.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 传染性疾病 传染性疾病
背景情况:
- 阿迪波金在调节对COVID-19等感染的炎症反应方面至关重要.
- 研究特定的阿迪波基因为COVID-19患者的治疗结果提供了洞察力.
研究的目的:
- 为了检查化学素,阿迪波涅克丁和莱普丁的预后价值.
- 评估它们在预测COVID后肺部后果方面的作用.
主要方法:
- 在住院COVID-19患者中测量了血清阿迪波金水平.
- 患者被监测了6个月的临床结果和肺部后果.
主要成果:
- 低化学素水平与预后不佳有关,并且与年龄负相关.
- 化学素/阿迪波内克的比率显示出预测肺部损伤的潜力.
- 丁水平与马-氨基转移酶负相关,在预后不佳的组中升高.
结论:
- 在COVID-19预后较差的患者中,化学素水平降低.
- 化学素/阿迪波内克的比率可以作为COVID-19后肺部继发症的预测标志物.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
相关概念视频
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia III: Complications and Assessment
